Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials: A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation the American Academy of Neurology Affirms the Value of This Science Advisory.
Circulation - United States
doi 10.1161/circulationaha.109.192272
Full Text
Open PDFAbstract
Available in full text
Date
May 26, 2009
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)